Treatment outcomes of triple class refractory multiple myeloma: a benchmark for new therapies. Leukemia Bal, S., Malek, E., Kansagra, A., Usmani, S. Z., Vij, R., Godby, K. N., Cornell, R. F., Kang, Y., Umyarova, E., Giri, S., Chhabra, S., Liedtke, M., Callander, N. S., Hari, P., Kumar, S., Costa, L. J. 2021

View details for DOI 10.1038/s41375-021-01471-3

View details for PubMedID 34802043